(Q73821856)
Statements
Phase II study of combined levamisole with recombinant interleukin-2 in patients with advanced malignant melanoma (English)
E T Creagan
K M Rowland
C G Kardinal
R F Marschke
R S Marks
scientific article published on 01 October 1997
No description defined